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Background: Obstructive Sleep Apnea (OSA) results in intermittent hypoxia leading to atrial remodeling, which,
among other things, facilitates development of atrial ﬁbrillation. While much data exists on the macrostructural
changes in cardiac physiology induced by OSA, there is a lack of studies looking for histologic changes in human
atrial tissue induced by OSA which might lead to the observed macrostructural changes.
Methods: A case control study was performed. Patients undergoing coronary artery bypass grafting (CABG) were
evaluated for OSA and categorized as high-risk or low-risk. The right atrial tissue samples were obtained during
CABG and both microscopic histological analysis and Sirius Red staining were performed.
Results: 18 patients undergoing CABG were included; 10 high-risk OSA and 8 low-risk OSA in evenly matched
populations. No statistically signiﬁcant difference between the two groups was observed in amount of
myocytolysis (p=0.181), nuclear hypertrophy (p=0.671), myocardial inﬂammation (p=n/a), amyloid depo-
sition (p=n/a), or presence of thrombi (p=n/a), as measured through routine H&E staining. As well, no statis-
tically signiﬁcant difference in interstitial and epicardial collagen was observed, as measured by Sirius Red
staining (for total tissue: p= 0.619: for myocardium: p= 0.776).
Conclusions: In this pilot study there were no observable histological differences in human right atrial tissue from
individuals at high- and low-risk for OSA. Further investigation would be required for more deﬁnitive results.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obstructive Sleep Apnea (OSA) is a largely underdiagnosed but com-
mon breathing disorder that affects approximately 5–15% of North
Americans [1,2]. The prevalence of atrial ﬁbrillation (AF) among pa-
tients with OSA has been reported at anywhere between 32 and 49%
[3–6]. OSA is known to be associated with signiﬁcant atrial structural
remodeling, including atrial enlargement and signiﬁcant conduction ab-
normalities [7–9]. It is thought that the electrical substrate for AF
resulting from OSA is due to these structural changes, which result in
increased sympathetic tone, systemic and pulmonary hypertension,
intermittent hypoxia, and inﬂammation [10–17].d Pacing, 76 Stuart St. Kingston
ersity, Department of Medicine,
387.
.
d Ltd. This is an open access article unNo previouswork hasmicroscopically compared human atrial tissue
between patients with and without OSA in order to characterize histo-
logical or pathological changes that might further explain the predispo-
sition for AF. Given previously described histological ﬁndings known to
be associatedwith AF [18–28], we postulate that similar ﬁndings will be
present in the atrial tissue of patients with OSA, which might offer fur-
ther insight as to why these patients are predisposed to developing
this arrhythmia. Herewe present a pilot study to investigatemicroscop-
ic differences in human atrial tissue induced by the presence of OSA.
2. Methods
2.1. Design
Patients presenting for elective Coronary Artery Bypass Grafting
(CABG) were prospectively screened for OSA using a modiﬁed Berlin
questionnaire (BQ), after obtaining appropriate consent. Patients wereder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Demographic Data (OSA: Obstructive Sleep Apnea; BMI: BodyMass Index; COPD: Chronic
Obstructive PulmonaryDisease; AF: Atrial Fibrillation; LVEF: Left Ventricular Ejection Frac-
tion; LAD: Left Atrial Diameter; RAV: Right Atrial Volume; RAVI: Right Atrial Volume
Index; PCAF: Post-CABG Atrial Fibrillation; CPAP: Continuous Positive Airway Pressure).
Total OSA low risk
(N = 8)
OSA high risk
(N = 10)
p
Age (years) 67.8 70.1 ± 6.9 66.0 ± 9.2 0.316
Gender (% male) 88.9 75 100 0.183
BMI (kg/m2) 27.6 26.5 ± 2.1 28.5 ± 5.4 0.337
Smoker (%) 27.8 12.5 40 0.314
Hypertension (%) 72.2 62.5 80 0.608
Diabetes (%) 16.7 12.5 20 1.000
COPD (%) 5.6 0 10 1.000
Asthma (%) 11.1 25 0 0.183
History AF (%) 0 0 0 n/a
LVEF (%) 55.4 56.8 ± 6.1 54.3 ± 8.2 0.493
LAD (mm) 38.8 38.1 ± 2.5 39.4 ± 4.8 0.610
RAV (mL) 50.4 52.3 ± 10.2 48.8 ± 15.3 0.591
RAVI (mL/m2) 27.4 29.0 ± 4.8 26.2 ± 4.0 0.180
Beta-blocker use (%) 61.1 75 50 0.367
Presence of PCAF (%) 50 50 50 1.000
Length of stay (days) 5.4 6.0 ± 2.1 4.9 ± 1.0 0.156
CPAP use (%) 0 0 0 n/a
72 E.M. van Oosten et al. / IJC Heart & Vasculature 6 (2015) 71–75followed until their discharge following CABG. The primary endpoint
was to perform histological analysis of atrial tissue in patients with
high- and low-risk OSA proﬁles. In particular, hematoxylin and eosin
(H&E) staining and Sirius Red staining were used to look at
myocytolysis, nuclear hypertrophy, myocardial inﬂammation and colla-
gen deposition/ﬁbrosis. Pre-, peri-, and post-operative data were also
collected. To maintain blinding, results of the questionnaire were not
shared with the patient or study personnel, nor correlated with surgical
outcomes until study completion. Internal Review Board approval from
our institution was obtained.
2.2. Population
We included a total of 18 patients presenting for CABG surgery at a
tertiary care hospital. Patients were grouped into two categories: 1.
High risk for OSA; 2. Low risk for OSA. The study population included
only stable patients undergoing elective CABG. Patients were excluded
if they had a history of atrial ﬁbrillation. Tissue samples were subse-
quently obtained from the right atrial appendage at the site of cannula-
tion during standard CABG procedure.
2.3. Assessment of OSA
Patients were screened for OSA and classiﬁed as high-risk or low-
risk using the modiﬁed BQ, as originally described by Netzer et al.
[29], andmodiﬁed by our group to account for individuals already diag-
nosed with OSA via polysomnography, as previously described [30],
(addendum1 in supplemental information). The BQ has been previous-
ly validated as a suitable correlate for polysomnography [29,31].
2.4. Atrial tissue collection
The right atrial tissue that is normally discarded during a standard
CABG was obtained by the operating cardiothoracic surgeon and the
sample was prepared as indicated below.
2.5. Histological analysis
After a 24 hour ﬁxation in 10% neutral buffered formalin the atrial
tissue was embedded in parafﬁn, sectioned at 4 μm thickness and
stained with H&E and Sirius red stains [32]. Histologic features were
assessed using variations of previously reported methods [18,33–35].
By consensus review of H&E sections, three pathologists graded cases
for myocytolysis (deﬁned as clearing of at least 10% of cell cytoplasm)
and nuclear hypertrophy (deﬁned as nuclear diameter twice that of
background myocytes) as absent/mild (10% or fewer cells), moderate
(11–20% of cells) and marked (N20% of cells). Using a variation of the
World Heart Federation system [36], interstitial lymphocytic inﬂamma-
tionwas graded in the 5most involved high power ﬁelds as absent/mild
(less than moderate), moderate (N14 cells/mm2 without myocyte ne-
crosis), or marked (N14 cells/mm2 with myocyte necrosis). Amyloid
and endocardial thrombus were recorded as present or absent.
To assess interstitial ﬁbrosis Sirius Red stained sections were
scanned using an Aperio CS slide scanner (Leica Biosystems, Buffalo
Grove, IL, USA) at 20×magniﬁcation. The imageswere viewed in Aperio
ImageScope software and annotated to include only myocardium for
analysis and exclude epicardium (which is normally Sirius red positive).
Analysiswas performed using theAperio Positive Pixel Count Algorithm
with default settings to determine the proportion of positive pixels in
the selected areas.
2.6. Statistical Analysis
2.6.1. For demographic information
Data were collected in Excel and imported into IBM SPSS (version
21.0 for Windows) for statistical analysis. Data were initially describedusingmeans and standard deviations for continuous data, and frequen-
cies and percentages for categorical data. This was followed by a univar-
iate analysis to assess the association of the collected data with the
outcomes, using one-way ANOVA and independent samples t-tests for
the continuous data and chi-square tests (Pearson or Fisher's Exact as
appropriate) for the categorical data. Length of stay was analyzed
using Spearman correlation (continuous data) and t-tests or one-way
ANOVA (categorical data). The Kruskal–Wallis Test andMann–Whitney
U were used in the event of non-normal distributions. Variables were
considered statistically signiﬁcant if they attained a p-value of b0.05, al-
though those close to signiﬁcance were retained if they were deemed
clinically relevant.
2.6.2. For histological data
All results are expressed as the mean +/− the standard deviation.
Independent samples t-tests were used to determine statistical signiﬁ-
cance between the low-risk and the high-risk OSA groups. A p-value
of 0.05 or less was considered signiﬁcant.
3. Results
Demographic and clinical characteristics are shown in Table 1. We
included right atrial tissue samples from 18 patients, 10 with a high-
risk proﬁle for OSA (two of which were previously conﬁrmed cases via
formal polysomnography) and 8 with a low-risk proﬁle for OSA.
Patients in each group were matched with respect to age and sex.
Patients were 89% male, with a mean age of 67.8 ± 8.2 years. While
not statistically signiﬁcant, there were more smokers in the high-risk
group (40% vs 12.5%). No difference between BMI in the two study
groups was detected, and the groups were otherwise well matched.
Furthermore, there was no difference in echocardiographic data
(right atrial volume, right atrial volume index, left atrial diameter, and
left ventricular ejection fraction; p = 0.591, 0.180, 0.610, and 0.493
respectively) noted between the two study groups.
Table 2 demonstrates the results of our histological analysis. There
was no statistical difference observed in atrial tissue between high-
and low-risk OSA patients with respect to myocytolysis (p = 0.181),
nuclear hypertrophy (p= 0.671), myocardial inﬂammation (p= n/a),
amyloid deposition (p = n/a), or presence of thrombi (p = n/a), as
quantiﬁed using routine H&E staining. Furthermore, statistical signiﬁ-
cance was not observed when using Sirius Red staining to assess
collagen deposition. Both total tissue (p = 0.619) and myocardium
(p = 0.776) were compared (Figs. 1 and 2). H&E stained sections
Table 2
Histological analysis results (OSA: Obstructive Sleep Apnea).
Total OSA low risk
(N = 8)
OSA high risk
(N = 10)
p
Histological analysis
Myocytolysis
Absent/mild (%) 5.6 0 10 0.181
Moderate (%) 83.3 75 90
Marked (%) 11.1 25 0
Nuclear hypertrophy
Absent/mild (%) 44.4 50 40 0.671
Moderate (%) 55.6 50 60
Marked (%) 0 0 0
Myocardial inﬂammation
Absent/mild (%) 100 100 100 n/a
Moderate (%) 0 0 0
Marked (%) 0 0 0
Presence of amyloid (%) 0 0 0 n/a
Presence of thrombus (%) 0 0 0 n/a
Sirius Red staining (collagen)
Total tissue (% pixels) 29.8 ± 6.9 30.7 ± 5.6 29.0 ± 8.0 0.619
Myocardium (% pixels) 21.7 ± 6.6 21.2 ± 4.7 22.1 ± 8.1 0.776
73E.M. van Oosten et al. / IJC Heart & Vasculature 6 (2015) 71–75showed variable degrees of myocytolysis and myocyte nuclear hyper-
trophy, which ranged from absent/mild to marked. No case showed
more than mild inﬂammation, amyloid was not identiﬁed in a single
case and no endocardial thrombus was present.
4. Discussion
This study demonstrated no observable microscopic changes in the
right atrial tissue in the high-risk OSA population as compared to the
low-risk OSA population, as measured by H&E staining and Sirius Red
staining. This is not in keeping with known structural ﬁndings as OSA
is known to be associated with signiﬁcant atrial remodeling. This has
been characterized to include atrial enlargement, reduction in voltage,
widespread conduction abnormalities, and longer sinus node recovery
[9].Wepostulated that thesemacrostructural changeswould have asso-
ciated changes on themicrostructural level, whichwas not borne out in
this study.
Much research has looked to investigate the relationship between
OSA and cardiac arrhythmias. Among several pathogenic mechanisms
arising from OSA that can lead to cellular remodeling in the atrium, in-
termittent hypoxia has been reported to be linked to an increased vul-
nerability to AF [37,38]. Studies have shown that intermittent hypoxia
can alter the expression and function of various cardiac ion channels
thus promoting the generation of arrhythmias [39]. Given that
microstructural changes associated with AF are well known [22] and
that OSA predisposes to AF [3], we further postulated that similar
changes would be seen in atrial tissue of patients with OSA as are seenFig. 1. Representative routinely stained atrial tissue sections from patients with A. low-risk
myocytolysis (arrow). No signiﬁcant differences were observed. No cases showed more than min atrial tissue of patients with AF. We chose to assess primarily
for myocytolysis, hypertrophy, inﬂammation, and ﬁbrosis/collagen
deposition, as changes in all of these microscopic ﬁndings have been
linked to AF [22]. Unfortunately, our pilot study did not ﬁnd any statis-
tically signiﬁcant changes.
It is worth noting that, while not reaching statistical signiﬁcance in
this population, smoking showed a trend towards the high-risk OSA
group. Although there were no associated histological changes, because
smoking is associated with ischemic heart disease this trend could, in
larger studies, become signiﬁcant enough to affect the histological anal-
ysis. Another factor worth mentioning in discussion is that all of the pa-
tients recruited in this studywere inherently presentingwith signiﬁcant
cardiovascular disease, requiring CABG. Cardiovascular disease is also
known to promote cardiac structural changes [40]. The average BMI of
our population was 27.6 kg/m2, and obesity, not only associated with
heart disease, is in and of itself associatedwith cardiac structural chang-
es and remodeling [41,42]. These confounders likely make any micro-
scopic changes caused by OSA difﬁcult to tease out in such a small
sample size; wewould expect that in patients without ischemic disease,
variation in histological changes caused by OSA would be more
pronounced.
A subgroup analysis of our population looking atmicroscopic chang-
es in the right atrial tissue in patients with known AF may have been
helpful to clarify our above results. However this was not undertaken
given the small sample size. Furthermore, AF was not highly prevalent
in our study population (two conﬁrmed cases in total), and none of
the high-risk OSA population was known to have AF.
While we report no positive ﬁndings in this study, this marks, to our
knowledge, the ﬁrst effort to microscopically compare human atrial tis-
sue in patients with and without OSA. Despite the lack of statistical sig-
niﬁcance, likely in part due to the small sample size, we feel that further,
higher powered studies microscopically comparing atrial tissue be-
tween patients with and without OSA could possibly reveal changes
that help explain the predisposition to AF. Expanding further analysis
to the left atrium may also help in characterizing microscopic tissue
changes associated with AF, as AF is predominantly a left atrial problem
in a majority of patients.
5. Limitations
The lack of statistical signiﬁcance in our ﬁndings is likely to have
arisen from a small sample size (n = 18). Further limitation arises
given the intrinsic differences that lie within the acquired tissue sam-
ples, and as a result of the premorbid medical conditions of these pa-
tients (as all were presenting for CABG). Furthermore, we were
limited in that surgical constraints allowed us a collection of only the
right atrial tissue and changes affecting the left atrium may be more
pronounced than the right given that AF is largely associated with leftOSA, with focal myocyte nuclear hypertrophy (arrow), and B. high-risk OSA with focal
ild inﬂammation (hematoxylin and eosin stain, 200×).
Fig. 2. Example of Sirius Red staining from atrial tissue from patients with A. low-risk OSA and B. high-risk OSA (positive staining at arrow). No signiﬁcant differences were observed
(Sirius red stain, 200×).
74 E.M. van Oosten et al. / IJC Heart & Vasculature 6 (2015) 71–75atrial pathology. This study is also importantly limited by the use of the
BQ as a surrogate for polysomnography; particularly limiting in a small
study, using formal polysomnography to categorize patients deﬁnitively
as having or not having sleep apnea would greatly strengthen any con-
clusions made.
6. Conclusions
In this pilot study there were no observable histological differences
in human right atrial tissue from individuals at high- and low-risk for
OSA. While these results suggest that OSA does not have an effect on
the right atrial tissue at a microscopic level, further investigation with
higher-powered studies would be required to more deﬁnitively come
to a conclusion in this regard.
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